Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial by O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof

Get full text

A Phase I/II Trial of Panobinostat in Combination with Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma by Maly, Joseph J., MD, Christian, Beth A., MD, Zhu, Xiaohua, PhD, Wei, Lai, PhD, Sexton, Jennifer L., MS, Jaglowski, Samantha M., MD, Devine, Steven M., BS MD, Fehniger, Todd A., PhD MD, Wagner-Johnston, Nina D., MD, Phelps, Mitch A., PhD, Bartlett, Nancy L., MD, Blum, Kristie A., MD

Get full text

Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) by Jaglowski, Samantha M., MD, MPH, Jones, Jeffrey A., MD, MPH, Flynn, Joseph M., DO, MPH, Andritsos, Leslie A., MD, Maddocks, Kami J., MD, Woyach, Jennifer A., MD, Blum, Kristie A., MD, Grever, Michael R., MD, Geyer, Susan Michelle, PhD, Heerema, Nyla A., PhD, Lozanski, Gerard, MD, Stefanos, Mona, BS, Hall, Nathan, MD, PhD, Nagar, Veena, MD, Munneke, Brian, PhD, West, Jamie-Sue, Neuenburg, Jutta K., MD, PhD, James, Danelle F., MD, MAS, Johnson, Amy J., PhD, Byrd, John C., MD

Get full text

Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) by O’Brien, Susan M., MD, Jones, Jeffrey A., MD, MPH, Furman, Richard R., MD, Coutre, Steven E., MD, Flinn, Ian W., MD, PhD, Burger, Jan A., MD, PhD, Blum, Kristie A., MD, Sharman, Jeff P., MD, Wierda, William G., MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy J., PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD

Get full text

Durable Responses Including Complete Responses in CLL Following Long Term Treatment With Single-agent Ibrutinib 420 mg by O'Brien, Susan, MD, Coutre, Steven, MD, Furman, Richard R., MD, Flinn, Ian W., MD, PhD, Burger, Jan, MD, PhD, Blum, Kristie, MD, Sharman, Jeff, MD, Jones, Jeffrey, MD, MPH, Wierda, William, MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy, PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD

Get full text